Company Maravai LifeSciences Holdings, Inc.
Equities
MRVI
US56600D1072
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.87 USD | -1.00% | +5.34% | +35.42% |
Business Summary
Number of employees: 650
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nucleic Acid Production
77.8
%
| 813 | 92.1 % | 225 | 77.8 % | -72.36% |
Biologics Safety Testing
22.2
%
| 70 | 7.9 % | 64 | 22.2 % | -8.23% |
Eliminations
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | -57.14% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
48.8
%
| 339 | 38.4 % | 141 | 48.8 % | -58.45% |
Asia Pacific
33.7
%
| 110 | 12.4 % | 97 | 33.7 % | -11.25% |
EMEA
17.3
%
| 433 | 49.0 % | 50 | 17.3 % | -88.47% |
Latin and Central America
0.2
%
| 1 | 0.1 % | 1 | 0.2 % | -34.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Martin
CEO | Chief Executive Officer | 49 | 22-09-29 |
Carl Hull
FOU | Founder | 66 | 14-02-28 |
Kevin Herde
DFI | Director of Finance/CFO | 53 | 17-04-30 |
Mike Houston
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kate Broderick
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Peter Leddy
ADM | Chief Administrative Officer | 59 | 22-06-26 |
Deb Hart
IRC | Investor Relations Contact | - | - |
Christine Dolan
PRN | Corporate Officer/Principal | 56 | 17-10-09 |
Kurt Oreshack
LAW | General Counsel | 44 | 20-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | 16-02-29 |
Sean Cunningham
BRD | Director/Board Member | 48 | 16-02-29 |
Gregory Lucier
BRD | Director/Board Member | 59 | 19-12-31 |
Susannah Gray
BRD | Director/Board Member | 63 | 20-10-31 |
Carl Hull
FOU | Founder | 66 | 14-02-28 |
John DeFord
BRD | Director/Board Member | 62 | 23-07-19 |
Director/Board Member | 46 | 16-02-29 | |
Murali Prahalad
BRD | Director/Board Member | 52 | 16-07-31 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 20-11-18 |
Anat Ashkenazi
BRD | Director/Board Member | 51 | 20-11-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 119,094,026 | 0 | 0 | 42.92 % |
Stock B | 1 | 132,654,801 | 108,048,832 ( 81.45 %) | 0 |
Company contact information
Maravai Lifesciences Holdings, Inc.
10770 Wateridge Circle Suite 200
92121, San Diego
+
http://www.maravai.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.42% | 1.18B | |
-19.60% | 10.94B | |
+64.70% | 3.75B | |
-31.09% | 2.27B | |
-10.77% | 2.25B | |
-26.86% | 1.54B | |
-2.40% | 754M | |
-35.10% | 469M | |
+14.91% | 340M | |
+14.40% | 224M |
- Stock Market
- Equities
- MRVI Stock
- Company Maravai LifeSciences Holdings, Inc.